HIGHLIGHTS
- who: Darko Antic from the Lymphoma Center, Clinic for Hematology, University Clinical Center have published the research work: Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL, in the Journal: (JOURNAL)
- what: The aim of this study was to assess the risk of thrombosis and bleeding in patients with CLL affected by severe COVID-19. The analysis showed that high CAR and D-dimer values were predictive of thrombosis occurrence also in the context of CLL. The study had several . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.